Recent Updates
Recently added Catalysts

Akanda Corp. Common Shares

AKANFDA catalysts, PDUFA dates & pipeline intelligence
$1.08
▼ -0.04 · -3.57%

Financials

Last updated
Revenue
R&D Expenses
Operating CF
Total Assets
Total Liabilities
Equity
Shares Out.
D/E Ratio
Dilution Watch
Quarterly Cash
Unlock full AKAN financials and dilution scoring
Quarter by quarter figures, cash trend and dilution risk.
Institutional-grade data · Cancel anytime
52W LOW $1.0252W HIGH $78.90
Volume
42.89 K
Value Traded
142.21 K
Short % Float
1.88%
Days to Cover
1.0
-18.8%Week
-64.71%1 Month
-86.6%3 Month
-89.42%6 Month

Cash Data

Unlock AKAN cash and runway
  • Monthly Burn
  • Burn Trend
  • Dilution Risk
  • SEC Filing

Key Stats

Market Cap
584.11 K
EPS (TTM)
-
P/E Ratio
-
Ent. Value
-
Total Shares
540.84 K
Float Shares
2.39 M
Insiders
9.30%
Institutions
0.02%

Upcoming Catalysts

FDA decisions, readouts and PDUFA dates · scored by probability of approval

Catalyst Drug / Treatment Stage Prob. of Approval Description Drug Type Therapeutic Area Source
PDUFA
2026
Example Drug
Treatment for example condition requiring FDA review
Phase 3Small MoleculeOncology-
Unlock every AKAN catalyst date and PoA score
Every FDA decision, readout and PDUFA date, with drug type, therapeutic area and a PoA score you can trade on.
Institutional-grade data · Cancel anytime
PoA blends historical approval base rates, trial design score and FDA review track record.

AKAN Catalyst Timeline

Dated clinical, regulatory and corporate events for Akanda Corp. Common Shares

Catalyst Timeline

Dated clinical, regulatory & corporate events for Akanda Corp. Common Shares

75Total events
3Upcoming
15Tier-1 (high impact)
2022 to 2026Coverage

Upcoming catalysts 2

T2Quarterly Update
Subscribe to view catalyst details
T3Manufacturing Milestone
Subscribe to view catalyst details

Event history 50

▲Product LaunchPost-Market
First cash lease payment collected from 200 km fiber network
▼Going ConcernCorporate
Received Nasdaq notice for minimum stockholders' equity deficiency
▲Quarterly UpdateCorporate
Received Nasdaq notice of regained compliance with periodic filing requirement
▲Quarterly UpdateCorporate
Filed Annual Report on Form 20-F for fiscal year 2025
◆Quarterly UpdateCorporate
Adjourned Special Meeting of Shareholders to be reconvened
▼Reverse Stock SplitCorporate
1-for-4.5 reverse stock split effective April 13, 2026
▼Quarterly UpdateCorporate
Special Meeting of Shareholders adjourned due to lack of quorum
▼Equity OfferingCorporate
Closing of $7.0 million convertible note offering
◆Equity OfferingCorporate
Closing of convertible note offering expected
▼Equity OfferingCorporate
Akanda announces $7.0 million convertible note offering
Unlock the full AKAN catalyst timeline
Every PDUFA date, readout, approval and corporate move, tiered by market impact and updated daily.
Institutional-grade data · Cancel anytime

Past FDA Catalysts and PDUFA Decisions

How AKAN actually traded into and out of each decision

Date Drug Catalyst Stage Reaction Event Move % Best Trade %
-Example Drug Phase 3 data readout Phase 3
Unlock all AKAN historical catalysts
Institutional-grade data · Cancel anytime
Reaction: 30 trading days around the event · Event Move: close to close on decision day · Best Trade: peak run-up from entry 10 days before the decision

Drug Pipeline Intelligence

Unlock the AKAN pipeline intelligence model
Every scored asset with PTRS, rNPV, enrollment velocity and trial design quality.
Institutional-grade data · Cancel anytime

Clinical Trial Results

Readouts, endpoints and source filings for every AKAN program

Drug Name Indication Phase Date Trial Results SummaryTitleSource
Example Drug Example indication for clinical evaluationPhase 32025-12-01The study met its primary endpoint demonstrating statistically significant improvement.Read MorePhase 3 Study Results AnnouncementRead More
Scroll for more · summaries link to the source press release
Unlock every AKAN trial readout
Institutional-grade data · Cancel anytime

Inside Trades

Unlock AKAN insider buying and selling
Monthly insider buys and sells against the stock price, with the insider sentiment reading.
Institutional-grade data · Cancel anytime
InsiderSideSharesPriceValueDate
HRT FINANCIAL LP10% OwnerSell -7,868 7,816 held$1.29 01/16/2026
Unlock the full AKAN insider trade log
Institutional-grade data · Cancel anytime

Hedge Fund 13F Activity

Fund % of Portfolio Current MV Shares Owned Activity
No hedge fund reported a 13F position in AKAN for Q2 2026.
Unlock every fund holding AKAN
Every 13F position with quarter over quarter share flow and average entry price.
Institutional-grade data · Cancel anytime
Unlock hedge fund flows in AKAN
Shares held by hedge funds each quarter, and who bought or sold.

AKAN Institutional Ownership Trends

AKAN Short Interest

Shares sold short, counted twice a month.

1.88%
Short % of Float
of tradable shares sold short
44.9K
Shares Sold Short
-6.0% vs prior count
1.0 Low
Days to Cover
trading days of normal volume to buy every short share back
2.0M
Avg Daily Volume
the average used for days to cover
Unlock AKAN short interest history
Two years of days to cover and shares sold short, with every count and its change.
Institutional-grade data · Cancel anytime

Options Data

Option Volume

Open Interest
Call OI
Put OI
Put-Call Ratio
OI 30-day avg
Today vs avg
Option Volume
Call Vol
Put Vol
Put-Call Ratio
Vol 30-day avg
Today vs avg

Option Chain Statistics

ExpiryCall VolPut VolVol P/CCall OIPut OIOI P/CIV CallIV Call OI-WtdIV Call Vol-WtdIV PutIV Put OI-WtdIV Put Vol-Wtd
Unlock AKAN option chain statistics
Per-expiry call and put volume, open interest, put-call ratios and implied volatility.
Institutional-grade data · Cancel anytime

Real-Time Option Chain

CallsStrikePuts
LastVolOILastVolOI
No data available
Unlock the live AKAN option chain
Live calls and puts by strike: last price, volume and open interest for every expiry.
Institutional-grade data · Cancel anytime

Calls vs Puts by Expiry

CallsPutsLog scale
Unlock AKAN options analytics
Institutional-grade data · Cancel anytime

Competitive positioning

How AKAN ranks across every disease it competes in

Competitive Position is a premium feature
See how AKAN ranks against every competitor across each disease it develops in: phase, best drug, trials and likelihood of approval.
Start free trial

AKAN News

-AKAN
Sep 4, 2026
AKANGeneral
▼ -8.7%on this news

First Towers & Fiber Corp. Delivers First Cash Flow from New 200 KM Fiber Network, Eyes Expansion with Client

Akanda Corp.'s subsidiary, First Towers & Fiber Corp., has achieved its first cash flow from a newly constructed 200-kilometer fiber network in Mexico. This milestone signifies a shift towards recurring revenue generation for the company. With technical delivery ahead of schedule and ongoing discussions for network expansion, FTF is well-positioned for future growth. The existing tower portfolio continues to provide stable income.

Read more →
-AKAN
Jun 18, 2026
AKANGeneral

Akanda Announces Receipt of Nasdaq Notice Regarding Minimum Stockholders' Equity Requirement

Akanda Corp. received a notification from Nasdaq indicating non-compliance with the minimum stockholders' equity requirement, as the company's equity was reported at -$11,990,437. Following the guidelines, the company must submit a plan to regain compliance within 45 days. If accepted, Nasdaq may allow an additional 180 days for Akanda to rectify its situation. The notification does not immediately affect the listing status of its shares on Nasdaq.

Read more →
-AKAN
Jun 12, 2026
AKANGeneral
▲ +20.5%on this news

Akanda Corp. Regains Compliance with Nasdaq Periodic Filing Requirement

Akanda Corp. has regained compliance with Nasdaq’s periodic filing requirement by submitting its Annual Report on Form 20-F for fiscal 2025. The Nasdaq informed the company that it was previously not in compliance due to a missed filing, but this issue has now been resolved. Akanda aims to provide accessible cannabis products and expand its operations in Mexico with fiber optic networks.

Read more →
-AKAN
May 22, 2026
AKANGeneral
▲ +15.6%on this news

Akanda Corp. Announces Receipt of NASDAQ Noncompliance

Akanda Corp. has announced that it is not in compliance with Nasdaq listing rules due to the failure to file its Annual Report on Form 20-F for the fiscal year ending December 31, 2025. The company is required to submit a plan by July 19, 2026, detailing how it intends to regain compliance, with no assurance that this plan will be accepted. If management fails to restore compliance in the stipulated timeline, the company could face delisting from Nasdaq.

Read more →
-AKAN
May 13, 2026
AKANConferences/Events

Notice of ADJOURNED Special Meeting of Shareholders IS HEREBY GIVEN THAT a special meeting of the shareholders (the "Meeting") of Akanda Corp. (the "Corporation")

Akanda Corp. has announced that its special meeting of shareholders, originally scheduled for March 31, 2026, has been adjourned to May 25, 2026. The meetings are important for fulfilling Nasdaq exchange requirements and to introduce new business. Shareholders can attend in person or via Zoom, though remote participants will not have voting rights. Proxies from previous meetings will be honored, and the corporation has extended the proxy submission deadline.

Read more →
-AKAN
Apr 29, 2026
AKANGeneral
▲ +48.6%on this news· ran to +180% by day 1

Akanda Adjourns Shareholder Meeting

Akanda Corp. announced the adjournment of its Special Meeting of Shareholders due to insufficient quorum. The meeting will reconvene on May 25, 2026, to allow more time for proxy solicitation. Shareholders who have voted do not need to act again, as their previous votes will still count. The company emphasizes the importance of shareholder participation for the reconvened meeting.

Read more →
-AKAN
Apr 9, 2026
AKANGeneral

Akanda Corp. Announces Reverse Stock Split

Akanda Corp. announced a 1-for-4.5 reverse stock split, which is set to take effect on April 13, 2026. This decision was approved by shareholders and the Board of Directors in previous meetings. The reverse split aims to reduce the number of outstanding shares from approximately 2.4 million to about 534.4 thousand. All shareholders will be affected uniformly, although adjustments will occur for any fractional shares. The company remains focused on its cannabis operations and expanding its fiber optic network in Latin America.

Read more →
-AKAN
Mar 31, 2026
AKANConferences/Events
▲ +16.2%on this news

AKANDA CORP. NOTICE OF SPECIAL MEETING TO BE HELD ON MARCH 31, 2026 AND MANAGEMENT INFORMATION CIRCULAR FEBRUARY 26, 2026 AKANDA CORP. NOTICE OF SPECIAL MEETING OF SHAREHOLDERS (the "Notice") NOTICE IS HEREBY GIVEN that

Akanda Corp. has announced a special meeting for shareholders scheduled for March 31, 2026, to be held in Toronto and available via Zoom. Shareholders must attend in person or provide a proxy to vote at the meeting. The company encourages shareholders to read the accompanying information circular for important details regarding the meeting agenda. The record date for determining eligible shareholders is set for February 25, 2026.

Read more →
-AKAN
Mar 26, 2026
AKANGeneral
▼ -12.9%on this news· ran to -25% by day 1shared move

Ontario Ministry of Government and Consumer Services Articles of Amendment Business Corporations Act Instructions For questions or more information to complete this form, please refer to the instruction page. Fields mark

The article provides detailed instructions from the Ontario Ministry of Government and Consumer Services regarding the Articles of Amendment under the Business Corporations Act. It outlines mandatory fields and necessary information for corporate filings, including details about the corporation's name, contact information, director information, and changes to shares and provisions. Specific amendments, such as the consolidation of shares, are also mentioned, emphasizing the legal requirements for ensuring all filings comply with the Act. A confirmation of authorization by the director and caution regarding penalties for misinformation are also included.

Read more →
-AKAN
Mar 26, 2026
AKANGeneral
▼ -12.9%on this news· ran to -25% by day 1shared move

Akanda Corp. Driving Recurring Revenue Growth: $2 Million Cash Flow Secured Through Fiber Acquisition Toronto, Ontario--(Newsfile Corp.

Akanda Corp. has announced a significant expansion of its dark fiber network, acquiring approximately 200 kilometers of infrastructure, which is expected to generate $2 million in contracted cash flow over ten years. This acquisition furthers the company's strategy to establish a high-margin, cash-generating digital infrastructure platform in a rapidly growing market in Mexico. The added network will increase total coverage to 900 kilometers, positioning Akanda to capture further revenue by leasing additional strands to various enterprises. The company's management is optimistic about this expansion, citing its potential to accelerate growth and enhance shareholder value.

Read more →
-AKAN
Feb 27, 2026
AKANGeneral
▲ +13.1%on this news

First Towers & Fiber Corp. Owns The Largest Dark Fiber Network In Central Mexico

Akanda Corp. and its subsidiary, First Towers & Fiber Corp., have announced plans to expand their dark fiber leasing operations in Central Mexico. The approximately 700-kilometre dark fiber network, the largest in the region, is already leased to Telefónica and Marcatel, with ample capacity for future customers. The scalable design of the network supports increased leasing opportunities, which the company expects to leverage to boost recurring revenue. With an established regional presence, FTF aims to meet the rising demand for high-capacity fiber infrastructure.

Read more →
-AKAN
Jan 23, 2026
AKANGeneral
▲ +11.1%on this news· ran to +34% by day 1

Akanda Announces Closing of $7.0 Million Convertible

Akanda Corp. announced the successful closing of a $7.0 million convertible note offering as part of a private placement transaction. The proceeds from this offering will be primarily used for marketing, working capital, and debt obligations. Despite this positive development, the company has stated that the notes are not registered under the Securities Act, which may restrict their sale in certain jurisdictions. Additionally, Akanda faces several challenges, including competition and the need to effectively manage its growth and debt.

Read more →
-AKAN
Jan 20, 2026
AKANGeneral
▲ +41.7%on this newsshared move

Akanda Announces $7.0 Million Convertible Note

Akanda Corp. announced a $7.0 million convertible note offering to institutional investors, expected to close on January 21, 2026. The funds raised will be allocated for marketing, working capital, and debt repayment. This move reflects the company's strategic financial planning and aims to bolster its operational capabilities.

Read more →
-AKAN
Dec 18, 2025
AKANGeneral
▼ -7.4%on this news· ran to -24% by day 3

Akanda Corp. Welcomes Momentum Towards Cannabis Reform in the United States

Akanda Corp. expresses support for the U.S. government's potential reclassification of cannabis from Schedule I to Schedule III, highlighting the importance of modernizing cannabis policies. The interim CEO emphasized the benefits of a science-led, public-health approach, which could enhance medical research and consumer safety while addressing illicit supply chains. The company advocates for reforms focused on measurable outcomes similar to Canada's comprehensive cannabis legislation. Akanda aims to provide high-quality cannabis products and improve wellness through its business operations.

Read more →
-AKAN
Nov 13, 2025
AKANGeneral

Researching Security Requirements For Full Cultivation License

Akanda Corp. is actively researching security requirements for obtaining a full cultivation license in Ontario. The company has extended its option on a British Columbia asset for two more years while intending to develop THC and CBD products. To prepare for future licensing inspections, Akanda plans to implement Health Canada-compliant security measures at its site. The company aims to leverage its strategic vision in the growing Canadian cannabis market, projected to expand significantly by 2030.

Read more →
-AKAN
Oct 30, 2025
AKANGeneral

Notice of ADJOURNED Special Meeting of Shareholders NOTICE IS HEREBY GIVEN THAT a special meeting of the shareholders (the " Meeting ") of Akanda Corp. (the " Corporation ") originally scheduled for

Akanda Corp. has adjourned its special meeting of shareholders originally scheduled for October 30, 2025, to November 28, 2025. This adjournment allows the company to meet Nasdaq exchange requirements and address new business. Shareholders can attend in person or watch the meeting via Zoom, although remote participants will have limited engagement rights. The meeting will cover original business as well as new proposals, and management urges a vote in favor of all resolutions presented.

Read more →
-AKAN
Oct 20, 2025
AKANGeneral

Akanda Corp. Increasing Its Cannabis Investment

Akanda Corp. is increasing its cannabis investment by extending its option on its British Columbia asset for two more years. The company is pursuing a full cultivation license to develop THC and CBD products at its facility on Gabriola Island, known for favorable growth conditions. This strategic move illustrates Akanda's commitment to solidifying its role in the global cannabis industry while focusing on high-quality cannabis production.

Read more →
-AKAN
Oct 16, 2025
AKANGeneral
▼ -5.1%on this newsshared move

Akanda To Accelerate Recurring Revenue with Expansion Of Up To 20

Akanda Corp. is undertaking a significant expansion initiative through its subsidiary First Towers & Fiber Corp., planning to construct or acquire up to 20 new cellular towers by the end of 2025. This strategic investment aims to enhance network capacity, strengthen coverage, and drive recurring revenue. Currently, FTF operates 30 revenue-generating towers and a 700-kilometer dark fiber network, and this expansion is set to solidify its position in Mexico's telecommunications sector. The initiative is expected to increase cash flow and align with the growing demand for mobile data and connectivity solutions in the region.

Read more →

About Akanda Corp. Common Shares

6 employees akandacorp.com
BIOPHARMAWATCH ELITE PLUS
Trade the next AKAN catalyst before the market reprices
Every FDA decision, PoA score, 13F move and dilution flag on this page, for 1,100+ biotech tickers. From $19/mo billed annually.
Cancel anytime